Psychomotor slowing, negative symptoms and dopamine receptor availability--an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients

Schizophrenia Research
A HeinzD R Weinberger

Abstract

Anhedonia and psychomotor slowing in schizophrenia have been attributed to a dysfunction of dopaminergic neurotransmission. To differentiate between disease and drug-induced negative symptoms, we examined eight drug-free and eight neuroleptic-treated schizophrenic patients. Positive and negative symptoms and extrapyramidal side effects were assessed using standardized rating scales (PSAS, AMDP, SANS). 'Reaction time' and 'motor speed' were measured using a computer-aided system and striatal dopamine D2/D3 receptor availability was assessed using [I-123]IBZM SPECT. Psychomotor reaction time, parkinsonism, affective flattening and avolition were increased in treated patients relative to the untreated cohort and were negatively correlated with dopamine D2/D3 receptor availability. Significant positive correlations were found between parkinsonism and affective flattening and between psychomotor slowing and avolition. Positive symptoms were not significantly associated with striatal IBZM binding. These findings support the hypothesis that neuroleptic-induced dopamine D2/D3 blockade in the striatum can mimic certain negative symptoms, such as affective flattening and avolition, and indicates that psychomotor testing may be helpful in...Continue Reading

References

Aug 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·N JordanJ A Cooper
Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·J FishmanB Viegener
Jan 1, 1991·Journal of Psychiatric Research·F SchwartzB Viegener
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Jan 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·A J McGennis
Aug 1, 1982·Journal of Abnormal Psychology·E Walker, M Green
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen
Sep 1, 1993·Brain Research. Brain Research Reviews·T E Robinson, K C Berridge
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·M B KnableD R Weinberger

❮ Previous
Next ❯

Citations

Dec 22, 2007·Psychopharmacology·Florian SchlagenhaufAndreas Heinz
Mar 29, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·A Heinz
Nov 25, 2000·Nuclear Medicine and Biology·A HeinzD R Weinberger
May 26, 2006·Journal of Clinical and Experimental Neuropsychology·Mark ZimmermannDieter Vaitl
Nov 10, 2006·Schizophrenia Bulletin·Manuel MorrensBernard Sabbe
May 11, 2010·Schizophrenia Bulletin·Andreas Heinz, Florian Schlagenhauf
Jan 30, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thomas W WeickertVenkata S Mattay
Nov 4, 2015·Frontiers in Human Neuroscience·Mingjun DuanDezhong Yao
Sep 1, 2015·Psychiatry Research·Sebastian Walther
Mar 17, 2010·Schizophrenia Research·Austin A WoolardStephan Heckers
Oct 12, 2012·Psychiatry Research·Izelle LabuschagneUNKNOWN TRACK-HD Investigators
Feb 23, 2010·Biological Psychiatry·Thomas W WeickertDaniel R Weinberger
May 27, 2014·Der Nervenarzt·V AderholdA Heinz
Jun 30, 2014·Psychopharmacology·Claudia HägeleAndreas Heinz
May 28, 2016·Schizophrenia Research·Matthias KirschnerStefan Kaiser
Apr 27, 2010·Pharmacology, Biochemistry, and Behavior·C L Danna, G I Elmer
Mar 16, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Vladimir M PogorelovWilliam C Wetsel
Sep 11, 2004·Journal of Psychopharmacology·R HalariT Sharma
Jan 17, 2007·Journal of Clinical Psychopharmacology·Manuel MorrensBernard G C Sabbe
Jun 10, 2005·Acta Psychiatrica Scandinavica. Supplementum·L P Voruganti, A G Awad
Apr 17, 2008·The Journal of Nervous and Mental Disease·Martin BrüneAlfonso Troisi
Aug 23, 2019·European Archives of Psychiatry and Clinical Neuroscience·Katherine S F DammeVijay A Mittal
Oct 19, 2001·CNS Drug Reviews·H Silver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

The British Journal of Social and Clinical Psychology
D W Johnston, A E Bursill
The British Journal of Psychiatry : the Journal of Mental Science
I MaurerF Jerusalem
The British Journal of Psychiatry : the Journal of Mental Science
R GrayS Oxborrow
The British Journal of Psychiatry : the Journal of Mental Science
J M Barber
© 2022 Meta ULC. All rights reserved